Endometriosis and cancer risk
review
OA: closed
public-domain-us
⚙
AI-generated summary
by claude@2026-06, 2026-06-08
ⓘ
This review examines the association between endometriosis and the risk of specific cancers like ovarian, endometrial, melanoma, basal cell carcinoma, and non-Hodgkin lymphoma, exploring shared underlying mechanisms.
⚙
AI-generated deep summary
by claude@2026-06, 2026-06-12
· read from full text
ⓘ
This paper reviews epidemiological and mechanistic evidence linking endometriosis, a common benign gynecologic condition, to subsequent cancer risk, with particular attention to ovarian cancer subtypes endometrioid and clear cell, and more modest correlations reported for other solid tumors such as endometrial cancer and melanoma. It highlights inconsistencies across studies and notes additional reported associations with melanoma, basal cell carcinoma, and non-Hodgkin lymphoma, emphasizing a multifaceted cancer-risk profile rather than a single cancer outcome. The review discusses potential shared mechanisms including chronic inflammation, oxidative stress, hormonal dysregulation, and genetic alterations involving ARID1A, PTEN, and KRAS, while also acknowledging that most people with endometriosis do not develop cancer and calling for further research to clarify molecular pathways. This paper is centrally about endometriosis—specifically the association between endometriosis and cancer risk, especially ovarian cancer subtypes and shared mechanisms.
Abstract
Endometriosis is one of the most common gynecological benign disease. Epidemiological evidence suggests a potential association between endometriosis and cancer risk. Accumulating evidence highlighted the risk of ovarian cancer, particularly endometrioid and clear cell subtypes. Few studies reported a modest correlation between endometriosis and various solid tumors including, endometrial cancer, and melanoma. However, inconsistencies remain across studies. Additionally, some data indicate an increased risk of melanoma, basal cell carcinoma, and non-Hodgkin lymphoma, underscoring the multifaceted nature of cancer risk in women with endometriosis. The underlying mechanisms include chronic inflammation, oxidative stress, hormonal dysregulation, and genetic alterations, such as mutations in ARID1A , PTEN , and KRAS , which contribute to the shared pathology between endometriosis and cancer. This paper explores the complex association between endometriosis and cancer, focusing on specific malignancies. This review emphasizes the importance of understanding the shared mechanisms between endometriosis and cancer. Although most women with endometriosis will not develop cancer, further research is essential to unravel the molecular pathways linking these conditions and enhance long-term outcomes for affected women.
Full text
1,870 characters
· extracted from
oa-doi-fallback
· click to expand
Endometriosis is one of the most common gynecological benign disease. Epidemiological evidence suggests a potential association between endometriosis and cancer risk. Accumulating evidence highlighted the risk of ovarian cancer, particularly endometrioid and clear cell subtypes. Few studies reported a modest correlation between endometriosis and various solid tumors including, endometrial cancer, and melanoma. However, inconsistencies remain across studies. Additionally, some data indicate an increased risk of melanoma, basal cell carcinoma, and non-Hodgkin lymphoma, underscoring the multifaceted nature of cancer risk in women with endometriosis. The underlying mechanisms include chronic inflammation, oxidative stress, hormonal dysregulation, and genetic alterations, such as mutations in ARID1A, PTEN, and KRAS, which contribute to the shared pathology between endometriosis and cancer. This paper explores the complex association between endometriosis and cancer, focusing on specific malignancies. This review emphasizes the importance of understanding the shared mechanisms between endometriosis and cancer. Although most women with endometriosis will not develop cancer, further research is essential to unravel the molecular pathways linking these conditions and enhance long-term outcomes for affected women.
Gynecologic cancer
European Journal of Cancer Prevention 34(3):p 276-278, May 2025. | DOI: 10.1097/CEJ.0000000000000965
Readers Of this Article Also Read
-
Incidence and prognosis of pediatric kidney malignant tumors diagnosed from...
-
The effects of the ketogenic diet on cancer treatment: a narrative review
-
A combined clinical and genetic model for predicting risk of ovarian cancer
-
Drug-specific and dosage effects of statins and the risk of cancer: a...
-
Ovarian cancer risk in relation to blood lipid levels and hyperlipidemia: a...
Text is read by the "Ask this paper" AI Q&A widget below.
Extraction quality varies by source — PMC NXML preserves structure
cleanly, OA-HTML may include some navigation residue, and OA-PDF can
have broken hyphenation. The publisher copy
(via DOI)
is the canonical version.
My notes (saved in your browser only)
⚙
Ask this paper
AI returns verbatim quotes from the full text
· source: oa-doi-fallback
ⓘ
Condition tags
endometriosis
MeSH descriptors
Endometriosis
Endometriosis
Endometriosis
Endometriosis
Endometriosis
Endometriosis
Endometriosis
Endometriosis
Endometriosis
Endometriosis
Endometriosis
Endometriosis
Endometriosis
Endometriosis
Endometriosis
Endometriosis
Endometriosis
Endometriosis
Endometriosis
Endometriosis
Citation neighborhood
(no data yet)
We don't have any in-corpus citations linked to this paper yet.
This is a recent paper (2025) — citers
typically take a year or two to land, and the OpenAlex reference
graph may still be filling in.
Source provenance
- europepmc
- last seen: 2026-07-28T06:14:09.330459+00:00
- pubmed
- last seen: 2026-07-28T06:10:41.175685+00:00
- unpaywall
- last seen: 2026-05-11T08:34:28.763810+00:00
License: public-domain-us
· commercial use OK
· attribution required
Courtesy of the U.S. National Library of Medicine